CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 69 enrolled
Drug / intervention
Paracetamol 3% +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02654860
NCT02654860Phase 2Completed

Two-part Study of Intrathecal Paracetamol Administered Immediately Before Spinal Anaesthesia in Patients Scheduled for Hip Replacement Surgery

Sintetica SA·interventional·Posted Jan 13, 2016·Updated Oct 27, 2021

In Brief

A Phase 2 clinical trial evaluating Paracetamol 3%, Placebo injection containing Saline solution 0.9%, and 1 other intervention for Phase 1: Pain Management and Phase 2: Pain Management. Completed, enrolled 69 participants across 1 site.

Detailed Summary

Two-part study of intrathecal paracetamol administered immediately before spinal anaesthesia in patients scheduled for hip replacement surgery

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSwitzerland
CollaboratorsCross S.A.

Timeline

Phase 2CompletedFinished
20162017201820192020202120222023202420252026
First PostedJan 13, 2016
Enrollment StartNov 1, 2016
Primary CompletionFeb 1, 2019
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 10.5 years ago

Interventions

Paracetamol 3%drug

Investigate the efficacy and safety of a single intrathecal injection of paracetamol,for post-operative analgesia of hip replacement surgery

Placebo injection containing Saline solution 0.9%drug

Injection containing sterile solution of Saline Solution 0.9 %. Study part 2 will be placebo-controlled. Each patient will be allocated to a treatment arm (one of the three paracetamol doses or placebo) according to a computer-generated randomisation list.

Hyperbaric Bupivacaine HCl 0.5%drug

NIMP, spinal anaesthetic before the surgical procedure